pH-Sensitive Immolative Polymer for Nucleic Acid Delivery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need for new materials and strategies to effectively deliver therapeutic agents, diagnostic probes, and research tools across cell membranes and biological barriers for various clinical and research applications, particularly for nucleic acids in vaccination strategies, cancer immunotherapy, and gene editing.

Innovation Solution

A cell-penetrating complex comprising a nucleic acid non-covalently bound to a cationic amphipathic polymer with a pH-sensitive imidolation domain and a lipophilic polymer domain, which facilitates the transport of nucleic acids across cellular membranes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If nucleic acids are delivered across cell membranes using conventional methods, then delivery efficiency is improved, but cellular toxicity increases

Engineering Contradiction:
Improvenucleic acid delivery efficiencyVSAvoidcellular toxicity
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The polymer undergoes pH-dependent conformational changes and degradation. At acidic endosomal pH, the polymer degrades to release nucleic acids, while at physiological pH it maintains a stable complex structure. This dynamic parameter change enables efficient delivery with reduced toxicity.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The system uses a composite structure combining cationic polymer and nucleic acid to form cell-penetrating complexes. The cationic nature facilitates membrane interaction while the overall composite structure controls toxicity and enables cellular uptake.

Inventive Principle:
Principle #40Composite materials

2Productivity

If cationic polymers are used to enhance nucleic acid binding and cellular uptake, then transfection efficiency is improved, but cytotoxicity increases

Engineering Contradiction:
Improvetransfection efficiencyVSAvoidpolymer-induced cytotoxicity
Core Design Contradiction:
ProductivityVSObject-generated harmful factors

Solution Approach 1:

The polymer is designed with pH-sensitive bonds that cause it to degrade at endosomal pH levels, releasing the nucleic acid cargo while the polymer itself breaks down into less toxic components, thereby reducing cytotoxicity after delivering its function.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The polymer acts as a disposable delivery vehicle that performs its function of binding and delivering nucleic acids, then degrades completely after use, eliminating persistent toxic effects from the polymer itself.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The complex enables efficient and effective delivery of nucleic acids into cells, demonstrating superior transfection efficiency and safety in various cell types and tissues, including reticulocytes and hematopoietic stem cells, with minimal toxicity.

Implementation Method 1

a cell-penetrating complex comprising a nucleic acid non-covalently bound to a cationic amphipathic polymer

Methodology Applied
Scientific EffectElectrostatic interaction: Electrostatics

Implementation Method 2

the cationic amphipathic polymer including a pH-sensitive immolation domain

Methodology Applied
Scientific EffectAcid hydrolysis: Hydrolysis

Data Source

PatentUS20240277854A1Immolative cell-penetrating complexes for nucleic acid delivery to the lung
Publication Date: 2024.08.22 THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV
  • US20240277854A1 patent drawing
  • US20240277854A1 patent drawing
  • US20240277854A1 patent drawing

AI summary

There are provided herein, inter alia, complexes, compositions and methods for the delivery of therapeutic, diagnostic and imaging agents, including nucleic acid, into a cell. The complexes, compositions and methods may facilitate complexation, protection, delivery and release of oligonucleotides and polyanionic cargos into lung cells and lung tissue, both in vitro and in vivo.